NCT00444223终止不适用
The Biodistribution of N-{4-[3'-[F-18] Fluoroethylphenyl)Amino]-6-quinazolinyl}-Acrylamide ([F-F18]FEQA) in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) and in Healthy Subjects: A Pilot Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 3
- 试验地点
- 2
- 主要终点
- Biodistribution of fluorine F 18 FEQA
研究概览
简要总结
RATIONALE: Fluorine F 18 FEQA may be an effective radioactive drug to use with positron emission tomography (PET) scans.
PURPOSE: This clinical trial is studying the use of fluorine F 18 FEQA in patients with stage III or stage IV non-small cell lung cancer and in healthy participants.
详细描述
OBJECTIVES:
- Determine the biodistribution of fluorine F 18 FEQA in patients with stage III or IV non-small cell lung cancer (NSCLC) and in healthy participants.
- Determine whether fluorine F 18 FEQA can be used as an imaging agent with positron emission tomography in patients with stage III or IV NSCLC.
OUTLINE: This is a pilot study.
Patients and healthy participants receive fluorine F 18 FEQA IV and then undergo whole-body dynamic scans comprising positron emission tomography.
Blood is collected during and after imaging to measure radioactivity.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Must meet 1 of the following criteria:
- •Diagnosis of non-small cell lung cancer by CT scan, bone scan, or biopsy
- •Stage III or IV disease
- •Clinically assessed with
- •Healthy participant
排除标准
- 未提供
结局指标
主要结局
Biodistribution of fluorine F 18 FEQA
时间窗: 1 day
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck CancerHead and Neck CancerNCT00245349University of Iowa9
已完成
3 期
Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate CancerProstate CancerNCT00520546Dr. Markus Hartenbach44
Unknown
不适用
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.CancerNCT00414934National Taiwan University Hospital100
已完成
不适用
The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory DiseasesInflammationCancerNCT01180907Jonsson Comprehensive Cancer Center10
已完成
1 期
Positron emission tomography using a newly-developed PET probe: [18F] Fluoroacetate (FACE) - human volunteer studyhealthy volunteerJPRN-UMIN000007575Shiga Medical Center Research Institute4